ADCT compared with FATE: revenue, margins and what each company keeps, and the suppliers and customers both name

ADCTADC Therapeutics SA

Mkt capRevenueRevenue

FATEFate Therapeutics Inc

Mkt capRevenueRevenue

Compare

ADCTADC Therapeutics SA

FATEFate Therapeutics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closesMethod ›

Moved together

ADCTwithFATE

Uncorrelated: r 0.25 · 500D.

Shared co-movers2with ADCTwith FATE

RGNXRegenxbio Inc.r 0.31r 0.38

RXRXRecursion Pharmaceuticals, Inc.r 0.26r 0.42

ADCT, solidFATE, hatchedr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

ADCTADC Therapeutics SA

1.56▲+1.16%· post 1.56

Mkt cap$197.9MRevenue$19MQ2 FY26Revenue$71MFY24

FATEFate Therapeutics Inc

2.04▲+1.49%· post 2.04

ClosedNov 3 '26

Mkt cap$244.4MRevenue$2MQ2 FY26Revenue$7MFY25

Compare

ClosedNov 3 '26

ADCTADC Therapeutics SA

FATEFate Therapeutics Inc

1.56▲+1.16%post 1.56

Price

2.04▲+1.49%post 2.04

$197.9M

Mkt cap

$244.4M

Q2 FY26$19M

Revenue

$2MQ2 FY26

FY24$71M

Revenue

$7MFY25

ADCT1.56▲+1.16%vsFATE2.04▲+1.49%ClosedNov 3 '26